Valuation: Iconovo AB

Market Cap 101M 10.42M 9.12M 8.42M 7.85M 14.8M 985M 15.06M 39.2M 486M 39.14M 38.27M 1.69B P/E 2026 *
-26.3x
P/E 2027 * -3x
Enterprise Value 61.98M 6.4M 5.6M 5.17M 4.82M 9.08M 605M 9.24M 24.06M 298M 24.03M 23.49M 1.04B EV / Sales 2026 *
2.14x
EV / Sales 2027 * -
Free-Float
39.74%
Yield 2026 *
-
Yield 2027 * -
1 day-6.67%
1 week-3.67%
1 month-12.13%
3 months-8.30%
6 months-7.89%
Current year-7.89%
1 week 1.04
Extreme 1.04
1.24
1 month 1.03
Extreme 1.03
1.29
Current year 0.91
Extreme 0.906
1.44
1 year 0.91
Extreme 0.906
2.79
3 years 0.91
Extreme 0.906
30
5 years 0.91
Extreme 0.906
97.8
10 years 0.91
Extreme 0.906
99.8
Manager TitleAgeSince
Chief Executive Officer 59 2025-10-30
Director of Finance/CFO 63 2023-03-31
Chief Operating Officer 62 2015-12-31
Director TitleAgeSince
Director/Board Member 61 2025-06-08
Chairman 65 2012-12-31
Director/Board Member 62 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
22-09-21Buy

Founder

500 0.0057%
22-09-20Buy

Chief Executive Officer

1,000 0.0113%
22-09-15Buy

Director

840 0.0095%
Change 5-day change 1-year change 3-year change Capi.($)
-6.67%-3.67%-44.74%-96.53% 10.42M
-1.40%-0.90%-38.12%-56.36% 12.81B
-2.47%+0.13%+65.41%+78.05% 3.74B
-2.28%+0.41%+312.88%+194.26% 3.38B
-1.37%+1.05%-31.90%-32.83% 2.4B
-1.86%-0.31%-48.12%-69.04% 1.82B
-2.10%-2.84%-28.60%-33.56% 1.76B
+0.73%-1.43%-0.72%-18.34% 1.34B
-0.58%+1.80%+25.93%+33.86% 979M
-.--%+0.71%-15.51%-23.22% 907M
Average -1.80%-0.31%+19.65%-2.37% 2.91B
Weighted average by Cap. -1.54%-0.45%+20.94%-1.73%

Financials

2026 *2027 *
Net sales 29M 2.99M 2.62M 2.42M 2.26M 4.25M 283M 4.33M 11.26M 140M 11.24M 10.99M 486M -
Net income -3M -310K -271K -250K -233K -440K -29.27M -447K -1.16M -14.44M -1.16M -1.14M -50.31M -34M -3.51M -3.07M -2.83M -2.64M -4.98M -332M -5.07M -13.2M -164M -13.18M -12.89M -570M
Net Debt -39M -4.02M -3.52M -3.25M -3.03M -5.71M -380M -5.82M -15.14M -188M -15.12M -14.78M -654M 1M 103K 90.31K 83.37K 77.77K 147K 9.76M 149K 388K 4.81M 388K 379K 16.77M
Logo Iconovo AB
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
Employees
12
Date Price Change Volume
26-06-30 SEK 1.050 -6.67% 25,228
26-06-29 SEK 1.125 +0.45% 110,454
26-06-26 SEK 1.120 +2.75% 21,931
26-06-25 SEK 1.090 +4.31% 21,441
26-06-24 SEK 1.045 -4.13% 151,354

Quarterly revenue - Rate of surprise